Development of a gas chromatography-mass spectrometry method for the analysis of sitagliptin in human urine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 74, Issue , 2013, Pages 71-76

  Uçaktürk, Ebru ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Derivatization; Gas chromatography mass spectrometry; Human urine; Sitagliptin; Validation

Indexed keywords

SITAGLIPTIN;

ACCURACY; ARTICLE; CALIBRATION; DERIVATIZATION; DIABETIC PATIENT; DRUG STRUCTURE; DRUG URINE LEVEL; HUMAN; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; URINALYSIS;

FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; PYRAZINES; TRIAZOLES;

EID: 84871886939     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.10.012     Document Type: Article

References (19)

1. Gupta V., Kalra S. Choosing a gliptin. Indian J. Endocrinol. Metab. 2011, 15(4):298-308.
2. Subbarayan S., Kipnes M. Sitagliptin: a review. Expert Opin. Pharmacother. 2011, 12(10):1613-1622.
3. Ahren B. Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin. Diabetes Metab. Syndr. Obes. 2010, 3:31-41.
4. Yanai H., Adachi H., Hamasaki H., Masui Y., Yoshikawa R., Moriyama S., Mishima S., Sako A. Effects of 6-month sitagliptin treatment on glucose and lipid metabolism, blood pressure, body weight and renal function in type 2 diabetic patients: a chart-based analysis. J. Clin. Med. Res. 2012, 4(4):251-258.
5. 14C]sitagliptin in humans. Drug Metab. Dispos. 2007, 35:533-538.
6. Scheen A.J. A review of gliptins in 2011. Expert Opin. Pharmacother. 2012, 13(1):81-99.
7. Bergman A.J., Cote J., Yi B., Marbury T., Swan S.K., Smith W., Gottesdiener K., Wagner J., Herman G.A. Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor. Diabetes Care 2007, 30:1862-1864.
8. Zeng W., Musson D.G., Fisher A.L., Chen L., Schwartz M.S., Woolf E.J., Wang A.Q. Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometry. J. Pharm. Biomed. Anal. 2008, 46:534-542.
9. Zeng W., Musson D.G., Fisher A.L., Wang A.Q. Determination of MK-0431 in human plasma using high turbulence liquid chromatography online extraction and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:1169-1175.
10. Nirogi R., Kandikere V., Mudigonda K., Komarneni P., Aleti R., Boggavarapu R. Sensitive liquid chromatography tandem mass spectrometry method for the quantification of sitagliptin, a DPP-4 inhibitor, in human plasma using liquid-liquid extraction. Biomed. Chromatogr. 2008, 22:214-222.
11. Hess C., Musshoff F., Madea B. Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 2011, 400:33-41.
12. Zeng W., Xu Y., Constanzer M., Woolf E.J. Determination of sitagliptinin human plasma using protein precipitation and tandem mass spectrometry. J. Chromatogr. B 2010, 878:1817-1823.
13. Rao R.N., Maurya P.K., Khalid S. Development of a molecularly imprinted polymer for selective extraction followed by liquid chromatographic determination of sitagliptin in rat plasma and urine. Talanta 2011, 85:950-957.
14. Swales J.G., Gallagher R.T., Denn M., Peter R.M. Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometry. J. Pharm. Biomed. Anal. 2011, 55:544-551.
15. Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, 2001.
16. Nevado J.J.B., Llerena M.J.V., Cabanillas C.G., Robledo V.R. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study. J. Chromatogr. A 2006, 1123:130-133.
17. Rodríguez-Flores J., Salcedo A.M.C., Llerena M.J.V., Fernández L.M. Micellar electrokinetic chromatographic screening of letrozole and its metabolite in human urine: validation and robustness/ruggedness evaluation. Electrophoresis 2008, 29:811-818.
18. Peters F.T. Stability of analytes in biosamples - an important issue in clinical and forensic toxicology?. Anal. Bioanal. Chem. 2007, 388:1505-1519.
19. World Anti-doping Agency Technical Document, May 8, 2010.